ARCHIVES

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

This article is from The Cancer Letter archive.

Vol. 33 No. 14 | April 13, 2007

Download PDF Visit The Full Archive

Related Articles

Center Directors To Hear “Creative” Approach to Funding Cancer Control

February 25, 1983

Komen Deal With KFC Yields Buckets Of Discord

April 23, 2010

Changes In Labels Of Anticancer Drugs Suggested; Response Is Slow

October 8, 1976

Dileep Bal Elected Cancer Society President, Young Is President-Elect, Baity Leads Board.

December 8, 2000

Clinical Trials: NCI Issues Clinical Alert On Chemo For Cervical Cancer

February 26, 1999

Cooperative Group Competing Renewals May Be Funded Only at 70-80% Of Amounts Recommended By CCIRC

January 2, 1981